Cargando...
An overview of antibody–drug conjugates in oncological practice
Antibody–drug conjugates (ADCs) are designed to manipulate the toxic efficacy of specific chemotherapeutic compounds, employing the high affinity of antibody-mediated delivery so as to drive them selectively to target cancer cells. These immunoconjugates encompass the general tendency towards precis...
Guardado en:
| Publicado en: | Ther Adv Med Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543133/ https://ncbi.nlm.nih.gov/pubmed/33088347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920962997 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|